DBPR728

Customer Review

Based on 1 Customer Validation

DBPR728 is an acyl prodrug of 6K465 that carries fewer hydrogen bond donors. 6K465 acts as an Aurora kinase inhibitor that destabilizes MYC family cancer proteins and has antitumor efficacy. DBPR728 has the potential to inhibit cancers that overexpress C-MYC and N-MYC, with a 10-fold increase in oral bioavailability compared to 6K465.

For research use only. We do not sell to patients.

  • Purity: 98.11%
  • CAS No.: 2702965-64-6
  • Formula: C29H37ClFN9O2
  • Molecular Weight:598.11
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

All Aurora Kinase Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00